Office-based neuromodulation for overactive bladder
Up to 80% patient response
Significant, sustainable improvements
No serious side-effects
Office-based Neuromodulation
Treats men and women with Overactive Bladder (OAB) and associated symptoms of urinary urgency, urinary frequency and urge incontinence
Retrograde neuromodulation via the tibial nerve to the sacral plexus
Initial series of twelve 30-minute weekly treatments, personalized ongoing treatment
Accommodate more patients using group appointments and staggered start times
Percutaneous tibial nerve stimulation (PTNS)
CPT® code 64566: established national and regional coverage policies
“… PTNS subject assessment of OAB symptoms was statistically significant for improvement or cure in 79.5% compared to 54.8% in the tolterodine arm (p = 0.01).”2
Ideal choice for refractory OAB
Least invasive 3rd line therapy in the AUA/SUFU OAB Guideline1*
Virtually no recovery time or lingering side-effects
Effective when other treatments fail
Provides superior subjective response to leading OAB drugs with statistically significantly reductions in OAB symptoms2,3
May be combined with behavioral and drug therapies
Cost-effective in short-term and beyond4
Remarkable Results
Up to 80% of patients respond2, 4, 6 -11
Clinically significant improvements in daytime and nighttime voiding frequency, leakage episodes and quality of life
Clinically significant improvements in daytime and nighttime voiding frequency, leakage episodes and quality of life
Consistent results in 3 RCTs, 3 durability studies, 2 meta-analyses and nearly 50 peer-reviewed articles
Sustainable Success
At 3 years follow-up, all QoL parameters remained markedly improved with about 1 treatment a month (all p<0.0001)10
At 3 years, 97% of patients followed had moderate or marked improvement in their symptoms compared to baseline10
77.5% of Urgent PC responders in a community based practice continued with long-term therapy with a treatment every 1-3 months11
